MIF-1 × LIMITLESS biotech - Lab Test, March 2025
Test results
About this test
This independent HPLC-UV-MS analysis confirms MIF-1 30mg from Limitless Life Nootropics at 99.66% purity. The testing was conducted on March 25, 2025 by MZ Biolabs, a third-party analytical laboratory based in Tucson, Arizona.
MIF-1 (Melanocyte-Inhibiting Factor-1, also known as Pro-Leu-Gly-NH2) is a synthetic tripeptide researched for its potential neuroprotective, opioid antagonist, and neuroendocrine modulation properties. A purity level of 99.66% indicates high-grade synthesis quality with minimal impurities. The chromatographic analysis identified MIF-1 as the predominant peak with two total detected peaks.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.